ECZEMA IMPETIGINOUS side effect
What is ECZEMA IMPETIGINOUS ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
ECZEMA IMPETIGINOUS and Recently Reported Side Effects
ECZEMA IMPETIGINOUS and 15 most Active Side Effect polls
ECZEMA IMPETIGINOUS and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Memantine Side Effects Report #5482084-5
Health Professional from GERMANY reported MEMANTINE problem on Sept 21, 2007. Female patient, 82 years of age, was diagnosed with dementia alzheimer's type and was treated with MEMANTINE. After drug was administered, patient experienced the following problems/side effects: beta haemolytic streptococcal infection, eczema impetiginous, eosinophil count increased, proteus infection, staphylococcal infection, urticaria, . MEMANTINE dosage: unknown. During the same period patient was treated with OMEPRAZOLE. Patient was hospitalized. Patient recovered.
Ebixa Side Effects Report #5409884-1
EBIXA problem was reported by a Health Professional from FRANCE on July 26, 2007. Female patient, 82 years of age, was diagnosed with dementia alzheimer's type and was treated with EBIXA. After drug was administered, patient experienced the following problems/side effects: beta haemolytic streptococcal infection, eczema impetiginous, eosinophil count increased, proteus infection, staphylococcal infection, urticaria, . EBIXA dosage: unknown. During the same period patient was treated with OMEPRAZOLE. Patient was hospitalized. Patient recovered.
Protopic Side Effects Report #5713695-7
Physician from JAPAN reported PROTOPIC problem on Apr 02, 2008. Male patient, child 7 years of age, was diagnosed with dermatitis atopic and was treated with PROTOPIC. After drug was administered, patient experienced the following problems/side effects: bacterial infection, eczema impetiginous, folliculitis, granuloma, impetigo, skin papilloma, . PROTOPIC dosage: unknown. Patient recovered.